动脉硬化
组蛋白
疾病
病态的
平滑肌
癌症研究
医学
病理
生物
内科学
生物化学
基因
作者
Xia-xia Zheng,Tian Zhou,Xinan Wang,Xiaohong Tong,Jiawang Ding
出处
期刊:Atherosclerosis
[Elsevier BV]
日期:2014-12-23
卷期号:240 (2): 355-366
被引量:49
标识
DOI:10.1016/j.atherosclerosis.2014.12.048
摘要
Atherosclerosis is the most common pathological process that leads to cardiovascular diseases, a disease of large- and medium-sized arteries that is characterized by a formation of atherosclerotic plaques consisting of necrotic cores, calcified regions, accumulated modified lipids, smooth muscle cells (SMCs), endothelial cells, leukocytes, and foam cells. Recently, the question about how to suppress the occurrence of atherosclerosis and alleviate the progress of cardiovascular disease becomes the hot topic. Accumulating evidence suggests that histone deacetylases(HDACs) play crucial roles in arteriosclerosis. This review summarizes the effect of HDACs and HDAC inhibitors(HDACi) on the progress of atherosclerosis.
科研通智能强力驱动
Strongly Powered by AbleSci AI